Bessemer Venture Partners IX Institutional L.P.'s Form 4 filing
NeueHealth, Inc. (NEUE) · filed Oct 19, 2022
- Accession no.
- 0001209191-22-054154
- Filed
- Oct 19, 2022, 8:59 PM ET
- Trade date
- Oct 17, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 derivative transaction. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bessemer Venture Partners IX Institutional L.P.CIK 0001624149 | 10% Owner |
| Bessemer Venture Partners IX L.P.CIK 0001655213 | 10% Owner |
| Deer IX & Co. L.P.CIK 0001655219 | 10% Owner |
| Deer IX & Co. Ltd.CIK 0001655220 | 10% Owner |
| 15 Angels II LLCCIK 0001713257 | 10% Owner |
| Deer X & Co. L.P.CIK 0001768637 | 10% Owner |
| Deer X & Co. Ltd.CIK 0001768677 | 10% Owner |
| Bessemer Venture Partners Century Fund Institutional L.P.CIK 0001787477 | 10% Owner |
| Bessemer Venture Partners Century Fund L.P.CIK 0001787478 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 17, 2022 | Common Stock | PPurchaseAcquired | +5,998,851 | $1,000.00F1 | +$8,500,000 | 8,500 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The Issuer's Series B Convertible Perpetual Preferred Stock ("Preferred Stock") is convertible at the option of the holder (subject to the expiration or early termination of the applicable waiting period, if any, under the HSR Act) into the number of shares of Issuer's common stock ("Common Stock") equal to the quotient of (a) the sum of (i) the liquidation preference (initially $1,000 plus increases for compounded dividends) plus (ii) the accrued dividends with respect to each share of Preferred Stock as of the applicable conversion date divided by (b) the conversion price (initially approximately $1.4169) as of the applicable conversion date, subject to anti-dilution adjustments.
Referenced by the price of 1 transaction in Table II.